14th May 2025 On-site event in Joki visitor and innovation centre Open Science & Impact Festival 2025 will take place in Visitor and Innovation [...] Event details
Inna Starskaia from Riitta Lahesmaa lab defends her PhD thesis “Early immune response in children developing type 1 diabetes” on Friday the 15th of May 2025. Her opponent is Professor Katri Lindfors from Tampere University. Event details
Karoliina Hirvonen from Riitta Lahesmaa lab defends her PhD thesis “Proteomics Insights into Type 1 Diabetes Development – Investigating Changes in Serum Proteome and the Role of Persistent Enterovirus Infection” on Thursday the 22nd of May 2025 at 12 pm in Arje Scheinin hall, 2nd floor, Dentalia, Turku. Her opponent is Professor Jochen Schwenk from Science for Life Laboratory, KTH Royal Institute of Technology, Sweden. Event details
Jochen M Schwenk is a Professor of Translational Proteomics at the KTH Royal Institute of Technology in Stockholm. With a Ph.D. in biochemistry from the University of Tübingen, Germany, Professor Schwenk conducts research at SciLifeLab in Solna since its inauguration in 2010. Event details
Sini Laakso, University of Helsinki: Exploring germinal center reaction and role of Epstein Barr virus by accessing deep cervical lymph nodes of patients with multiple sclerosis Event details
The Finnish Society for Bioinformatics and CompLifeSci are proudly joining forces to organize the Bioinformatics Day on the 6th of June in Cave Auditorium from 9 am to 4 pm, followed by a networking event at Circus in ElectroCity from 4pm to late. Event details
UTU Faculty of Medicine together with Turku BioImaging and the Field of View research program will organize a Minisymposium, “Future of Imaging”, on 13 June [...] Event details
Karoliina Hirvonen recently completed her Ph.D. at the Turku Bioscience Centre, University of Turku and Åbo Akademi University in Finland, focusing on proteomics patterns of type 1 diabetes risk and progression. Using mass spectrometry-based proteomics, she has studied temporal changes in plasma and serum from children with a HLA-conferred risk of type 1 diabetes and newly diagnosed individuals. Event details
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
